HCP - HCP, Inc.

NYSE - NYSE Delayed Price. Currency in USD
31.83
+0.04 (+0.13%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close31.79
Open31.75
Bid31.83 x 1000
Ask31.84 x 3100
Day's Range31.75 - 32.17
52 Week Range23.30 - 32.23
Volume4,234,917
Avg. Volume3,075,204
Market Cap15.425B
Beta (3Y Monthly)0.46
PE Ratio (TTM)13.95
EPS (TTM)2.28
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & Yield1.48 (4.97%)
Ex-Dividend Date2019-05-03
1y Target Est32.00
  • HCP Announces Closing of Upsized $2.5 Billion Revolving Credit Facility and New $250 Million Term Loan Facility
    PR Newswire2 days ago

    HCP Announces Closing of Upsized $2.5 Billion Revolving Credit Facility and New $250 Million Term Loan Facility

    IRVINE, Calif. , May 23, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that it has closed an amended and restated credit agreement providing for a $2.5 billion unsecured revolving credit facility ...

  • TheStreet.com3 days ago

    Former Dividend Aristocrat HCP Is On the Mend

    Nowhere is this more evident than the list of Dividend Aristocrats, a select group of 57 stocks with 25-plus years of consecutive dividend growth. It takes at least 25 years of uninterrupted dividend increases each year, no matter the economic climate, to make the list of Dividend Aristocrats. Until 2016 the real estate investment trust (REIT) that specializes in health care properties had maintained a streak of more than 30 annual dividend increases in a row before problems with a troubled tenant forced it to cut its dividend.

  • Health Care Digest: Cancer's show-and-tell meeting, a new biotech building rises and lupus patients' plea
    American City Business Journals5 days ago

    Health Care Digest: Cancer's show-and-tell meeting, a new biotech building rises and lupus patients' plea

    Bay Area companies are gearing up for ASCO, HCP's Brisbane biotech building is on the rise and more in our Health Care Digest.

  • InvestorPlace5 days ago

    7 Assisted-Living Stocks to Buy Now

    One of the painful but crucial lessons that the re-escalating trade war has taught us is that anything can happen. Just a few weeks ago, a resolution between the U.S. and China appeared an inevitability. Now, even the idea of getting together for talks is questionable. That said, not all stocks to buy are vulnerable to unexpected sentiment shifts.If you're seeking a market segment that will likely produce strong gains over the next decade, it's time to look at assisted-living stocks. Elderly care operates on two core principles. First, it's our moral and ethical obligation to help those that cannot help themselves. Second, aging happens to everyone. Therefore, these specialized-care facilities will essentially exist forever.Other fundamental factors support the case for assisted-living stocks to buy. The biggest tailwind is the sheer size of the baby boomer demographic. Between 1946 and 1964, the U.S. experienced 76 million births. By 2012, 11 million of this generation had died, but that still leaves 65 million survivors. That's a lot of folks that will seek care during their golden years.InvestorPlace - Stock Market News, Stock Advice & Trading TipsMoreover, advancing technologies in medicine and nutrition have noticeably increased our ability to extend our life. True, life expectancy is falling in this country. However, much of that can be attributed to the opioid crisis, which largely affects younger Americans. Overall, though, the point stands: healthcare innovations have had a net positive impact on baby boomers, which in turn affects assisted-living stocks to buy. * 7 Stocks to Buy that Lost 10% Last Week Best of all, the demand exists irrespective of economic or market conditions. It's an area that politically, Washington power-brokers cannot simply gloss over. Unlike discretionary sectors, specialized care levers a very human face. With that, here are seven assisted-living stocks to buy: Welltower (WELL)One of the attributes that attracted me to Welltower (NYSE:WELL) was that it's among Fortune's most admired companies of 2019. From a PR perspective, that's a huge story. As you probably know, assisted-living stocks don't enjoy the greatest of reputations due to scandalous stories of senior abuse.But as an investor, WELL stock provides many other substantive points to chew on. Primarily, shares have performed admirably this year, gaining over 18% since the January opener. Not only that, WELL recovered quickly from last year's broader market selloff. It ended 2018 with a return of 15%, whereas many other companies floundered.If that doesn't convince you to put WELL among your list of stocks to buy, consider its dividend. With a 4.4% yield, this can provide comfortable support should the markets experience a downturn. Ensign Group (ENSG)If you want pure exposure to assisted-living stocks to buy, take a good look at Ensign Group (NASDAQ:ENSG). Headquartered in Mission Viejo, California, ENSG stock is levered toward a robust local economy. Moreover, it offers comprehensive solutions for the elderly, including in-house therapy and hospice care.As with Welltower, ENSG stock exhibits tremendous resilience, even in the face of troubling market conditions. It absorbed a sharp blow during the broader selloff in late 2018. However, shares quickly bounced back. By the second half of February, ENSG had recovered all of its prior losses and then some. * 10 Baby Boomer Stocks to Buy That said, Ensign Group's equity is more representative of growth names than say dividend stocks to buy. For instance, ENSG is up 49% year-to-date, but only offers a miniscule 0.33% yield. Still, if you want to bet on extremely favorable demographics, Ensign is a great idea. Omega Healthcare Investors (OHI)Another strong name among assisted-living stocks to buy is Omega Healthcare Investors (NYSE:OHI). After working through some operational issues, management started this year off on an aggressive footing. In the first quarter, Omega bought out MedEquities Realty Trust (NYSE:MRT), which should boost the operational profile of OHI stock.However, you wouldn't guess that Omega was running on less than 100% of its cylinders by looking at its chart. On a year-to-date basis, OHI stock is up slightly over 15%. Last year, shares returned 40%. As you might imagine, the company hardly blinked during the recent downturn.I expect more of the same should the economy go sour due to a prolonged U.S.-China trade war. Recent quarterly revenues suggest that management is likely to overcome miscues from the past. Also, OHI stock pays out a very generous 7% dividend yield, which should attract shelter-seeking investors. HCP (HCP)A key advantage in acquiring assisted-living stocks to buy is their inverse correlation to current market conditions. For instance, while the benchmark S&P 500 index is down roughly 2% this month, senior-care specialist HCP (NYSE:HCP) has gained almost 7%.It was the same story last year. In the final quarter of 2018, the S&P 500 dropped 10%. On the other hand, HCP stock shot up just under 10% over the same time frame.I expect a similar dynamic if the markets slow down due to trade-war related complications. As with the other organizations in this segment, HCP stock will enjoy consistent, if not growing demand. Furthermore, HCP levers wider coverage of the healthcare sector, including life science, hospital and medical-office properties. * 7 A-Rated Healthcare Stocks for Industry Expansion Finally, HCP pays out a generous 4.7% dividend. Typically, income-generating companies fare better than pure growth names during a bear market. That's one more reason to put HCP in your list of stocks to buy! National HealthCare (NHC)Admittedly, some of the top names among assisted-living stocks represent speculation toward a corporate turnaround. What I like about National HealthCare (AMEX:NHC), though, is their "steady as she goes" financials. For instance, over the past four years, revenue for NHC stock has grown consecutively. This trend continued up to its most recent first quarter of 2019 earnings report.Granted, the growth rate isn't anything to write home about, which is essentially low single digits. But with the massive demographic tailwind that NHC stock benefits from, I'm not sure if they need crazy growth. Approximately 10,000 baby boomers retire each day, which will eventually translate to a robust clientele.Plus, National HealthCare pays out a 2.6% dividend yield. While the payout isn't as attractive as some of the other stocks to buy that I mentioned, the company's upwardly trekking sales is a significant positive. Capital Senior Living (CSU)While assisted-living stocks generally have a boring reputation -- how many of you got really jazzed about this segment? -- not all sector players fit that description. If you're the type to mix your gambling with elderly care, Capital Senior Living (NYSE:CSU) may be right for you.However, I don't want to mislead you in any way: CSU stock is one of the riskiest investments, both in assisted living and the broader markets. Last year was particularly awful for the organization, which suffered from slowing revenues and widening net-income losses. This dynamic was unhelpful to its overbearing long-term debt, to say the least. * 10 Stocks to Sell Before They Tank Your Portfolio Still, some hope exists for a turnaround. Revenue in Q1 was in line with the year-ago haul, suggesting that the sales bleed has stopped. Also, CSU stock has stabilized since hitting rock-bottom in March. It's super-risky, but that's sort of the point. Brookdale Senior Living (BKD)Brookdale Senior Living (NYSE:BKD) is a contradiction. On one hand, it levers the fundamentals that should make BKD stock a top player in the markets. Despite many troubled years, Brookdale is still the nation's top senior-housing owner and operator.But on the other hand, we've got to talk about those troubles. Since 2016, Brookdale's annual revenue has declined consecutively. Even worse, its Q1 2019 sales haul of $1 billion slipped more than 12% year-over-year. It has a sizable debt load and its net-income losses have widened considerably over the years.As a result, BKD stock has fallen into the dumps. But if you're a diehard contrarian, Brookdale may have something for you. Again, it's the top senior-housing operator in America. When you factor in the baby boomer demographic wave, BKD might make some big surprises.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Sell Before They Tank Your Portfolio * Top 7 Dow Jones Stocks of 2019 -- So Far * 5 Low-Priced, High-Potential Tech Stocks to Buy Compare Brokers The post 7 Assisted-Living Stocks to Buy Now appeared first on InvestorPlace.

  • CORR vs. HCP: Which Stock Should Value Investors Buy Now?
    Zacks9 days ago

    CORR vs. HCP: Which Stock Should Value Investors Buy Now?

    CORR vs. HCP: Which Stock Is the Better Value Option?

  • HCP Named to CR Magazine's 100 Best Corporate Citizens List for 2019
    PR Newswire10 days ago

    HCP Named to CR Magazine's 100 Best Corporate Citizens List for 2019

    IRVINE, Calif. , May 15, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that it was named to Corporate Responsibility (CR) Magazine's 100 Best Corporate Citizens List for 2019.  The roster ...

  • Bank of America: 10 Stocks To Survive A 'Full-Blown Trade War'
    Investopedia10 days ago

    Bank of America: 10 Stocks To Survive A 'Full-Blown Trade War'

    While many Wall Street firms are looking for equities than can weather a short-term trade conflict, Bank of America has screened more stringently for a hardier group of stocks: ones that can survive a worst-case or "full-blown" trade war between the world's two economic superpowers.

  • Health Care REIT Charts Not Looking So Healthy
    Investopedia16 days ago

    Health Care REIT Charts Not Looking So Healthy

    Health care REITs face some unique challenges despite favorable demographics. Let's give the charts a health check.

  • Markit19 days ago

    See what the IHS Markit Score report has to say about HCP Inc.

    HCP Inc NYSE:HCPView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for HCP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.88 billion over the last one-month into ETFs that hold HCP are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Financials sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. HCP credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Thomson Reuters StreetEvents22 days ago

    Edited Transcript of HCP earnings conference call or presentation 2-May-19 4:00pm GMT

    Q1 2019 HCP Inc Earnings Call

  • Is HCP, Inc.'s (NYSE:HCP) ROE Of 17% Impressive?
    Simply Wall St.22 days ago

    Is HCP, Inc.'s (NYSE:HCP) ROE Of 17% Impressive?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...

  • HCP Inc (HCP) Q1 2019 Earnings Call Transcript
    Motley Fool23 days ago

    HCP Inc (HCP) Q1 2019 Earnings Call Transcript

    HCP earnings call for the period ending March 31, 2019.

  • HCP's Q1 FFO Surpasses, Revenues Miss Estimates, NOI Up
    Zacks24 days ago

    HCP's Q1 FFO Surpasses, Revenues Miss Estimates, NOI Up

    HCP's first-quarter 2019 results indicate decent performance of the company's life-science and medical-office segments. Yet, tepid performance of seniors-housing portfolio remains a drag.

  • HCP (HCP) Q1 FFO Beat Estimates
    Zacks24 days ago

    HCP (HCP) Q1 FFO Beat Estimates

    HCP (HCP) delivered FFO and revenue surprises of 2.33% and -1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press24 days ago

    HCP: 1Q Earnings Snapshot

    IRVINE, Calif. (AP) _ HCP Inc. (HCP) on Wednesday reported a key measure of profitability in its first quarter. The results surpassed Wall Street expectations. The real estate investment trust, based in Irvine, California, said it had funds from operations of $212 million, or 44 cents per share, in the period.

  • HCP Reports First Quarter 2019 Results
    PR Newswire24 days ago

    HCP Reports First Quarter 2019 Results

    IRVINE, Calif. , May 1, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced results for the first quarter ended March 31, 2019. For the quarter, we generated net income of $0.13 per share, NAREIT ...

  • Will Senior Housing Softness Impact HCP in Q1 Earnings?
    Zacks27 days ago

    Will Senior Housing Softness Impact HCP in Q1 Earnings?

    HCP's premium MOB and life-sciences portfolio will likely perform well in first-quarter 2019, mitigating the challenges tormenting the senior housing market.

  • HCP Declares Quarterly Cash Dividend on Common Stock
    PR Newswirelast month

    HCP Declares Quarterly Cash Dividend on Common Stock

    IRVINE, Calif. , April 25, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.  The dividend will ...

  • 3 Dividend Stocks That Pay You More Than Pepsi Does
    Motley Foollast month

    3 Dividend Stocks That Pay You More Than Pepsi Does

    Looking for some stocks with higher yields than PepsiCo's 3%? Take a look at these three.

  • Healthcare Realty Completes MOB Buyouts in Potential Markets
    Zacks2 months ago

    Healthcare Realty Completes MOB Buyouts in Potential Markets

    Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.

  • HCP to Report First Quarter 2019 Financial Results and Host Conference Call/Webcast
    PR Newswire2 months ago

    HCP to Report First Quarter 2019 Financial Results and Host Conference Call/Webcast

    IRVINE, Calif. , April 4, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) is scheduled to report its first quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, ...

  • Here’s What Hedge Funds Think Of HCP, Inc. (HCP)
    Insider Monkey2 months ago

    Here’s What Hedge Funds Think Of HCP, Inc. (HCP)

    We can judge whether HCP, Inc. (NYSE:HCP) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their best ideas. […]

  • Kayne Anderson sells two South Florida properties for $38M
    American City Business Journals2 months ago

    Kayne Anderson sells two South Florida properties for $38M

    Kayne Anderson Real Estate Advisors sold two senior living properties in Palm Beach County, one a completed building and the other a development site, for a combined $38.05 million. In the larger deal, ...

  • AbbVie's big acquisition blowup: A one-off or an omen?
    American City Business Journals2 months ago

    AbbVie's big acquisition blowup: A one-off or an omen?

    AbbVie swung the axe a year before it is expected to move into nearly a half-million square feet as the cornerstone tenant in BioMed Realty's Gateway of Pacific project in South San Francisco. One thing is sure: Corporate decisions sometimes can be as capricious as science.